# Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimens

> **NCT02634190** · — · COMPLETED · sponsor: **Hologic Deutschland GmbH** · enrollment: 10000 (actual)

## Conditions studied

- Human Papilloma Virus Infection

## Interventions

- **OTHER:** Thinprep® LBC
- **OTHER:** APTIMA® HPV Assay
- **OTHER:** HR HC2® HPV DNA
- **OTHER:** Colposcopy

## Key facts

- **NCT ID:** NCT02634190
- **Lead sponsor:** Hologic Deutschland GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2021-06
- **Final completion:** 2021-12
- **Target enrollment:** 10000 (ACTUAL)
- **Last updated:** 2024-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02634190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02634190, "Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimens". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02634190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*